In the triple-negative breast cancer MDA-MB-231 cell line, sulforaphane enhances the intracellular accumulation and anticancer action of doxorubicin encapsulated in liposomes. (Record no. 29252262)

MARC details
000 -LEADER
fixed length control field 01601 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518015919.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201906s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1873-3476
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.ijpharm.2019.01.008
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Mielczarek, Lidia
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20190613
245 00 - TITLE STATEMENT
Title In the triple-negative breast cancer MDA-MB-231 cell line, sulforaphane enhances the intracellular accumulation and anticancer action of doxorubicin encapsulated in liposomes.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. International journal of pharmaceutics
Date of publication, distribution, etc. Mar 2019
300 ## - PHYSICAL DESCRIPTION
Extent 311-318 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibiotics, Antineoplastic
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anticarcinogenic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line, Tumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Survival
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Doxorubicin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Synergism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Isothiocyanates
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Liposomes
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfoxides
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Triple Negative Breast Neoplasms
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Krug, Pamela
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mazur, Maciej
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Milczarek, Małgorzata
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chilmonczyk, Zdzisław
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wiktorska, Katarzyna
773 0# - HOST ITEM ENTRY
Title International journal of pharmaceutics
Related parts vol. 558
-- p. 311-318
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.ijpharm.2019.01.008">https://doi.org/10.1016/j.ijpharm.2019.01.008</a>
Public note Available from publisher's website

No items available.